
Sign up to save your podcasts
Or


Attention Deficit/Hyperactivity Disorder, or ADHD, is currently thought to affect around one in 20 of the world’s population, making it one of the most prevalent types of neurodivergence. Despite this, the condition is still surrounded by stigma, misunderstanding and significant challenges in diagnosis.
In this episode, we’re joined by Prof Ellie Dommett, a neuroscientist based at King’s College London, to talk about the latest thinking on this common neurodevelopmental condition.
She explains why, despite its prevalence, ADHD is still commonly misunderstood, why it’s frequently diagnosed later in life, and also tells us about her work on developing effective non-pharmaceutical treatments to help those living with the disorder.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
By Our Media4.4
6969 ratings
Attention Deficit/Hyperactivity Disorder, or ADHD, is currently thought to affect around one in 20 of the world’s population, making it one of the most prevalent types of neurodivergence. Despite this, the condition is still surrounded by stigma, misunderstanding and significant challenges in diagnosis.
In this episode, we’re joined by Prof Ellie Dommett, a neuroscientist based at King’s College London, to talk about the latest thinking on this common neurodevelopmental condition.
She explains why, despite its prevalence, ADHD is still commonly misunderstood, why it’s frequently diagnosed later in life, and also tells us about her work on developing effective non-pharmaceutical treatments to help those living with the disorder.
Learn more about your ad choices. Visit podcastchoices.com/adchoices

877 Listeners

602 Listeners

767 Listeners

91 Listeners

261 Listeners

343 Listeners

959 Listeners

411 Listeners

415 Listeners

220 Listeners

849 Listeners

363 Listeners

79 Listeners

477 Listeners

115 Listeners